ABLAVAR (gadofosveset trisodium injection) Injection has been administered to humans up to a dose of 0.15 mmol/kg (5 times the clinical dose). No ABLAVAR (gadofosveset trisodium injection) overdoses were reported in clinical trials. In the event of an overdose, direct treatment toward the support of all vital functions and prompt institution of symptomatic therapy. Gadofosveset has been shown to be removed by hemodialysis using a high flux dialysis procedure [see CLINICAL PHARMACOLOGY].

History of a prior allergic reaction to a gadolinium-based contrast agent.

Last reviewed on RxList: 2/9/2011
This monograph has been modified to include the generic and brand name in many instances.